Tissue distribution and cardiac metabolism of 3-iodothyronamine

Endocrinology

Volumn 151, Issue 10, 2010, Pages 5063-5073

  Saba, Alessandro ^a,b   Chiellini, Grazia ^a   Frascarelli, Sabina ^a   Marchini, Maja ^a   Ghelardoni, Sandra ^a   Raffaelli, Andrea ^d   Tonacchera, Massimo ^a   Vitti, Paolo ^a   Scanlan, Thomas S ^c   Zucchi, Riccardo ^a  

^a UNIVERSITY OF PISA   (Italy)

^b CNR   (Italy)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d Consiglio Nazionale Delle Ricerche Istituto di Chimica dei Composti Organo Metallici ^*

Author keywords

[No Author keywords available]

Indexed keywords

3 IODOTHYROACETIC ACID; 3 IODOTHYRONAMINE; AMINE OXIDASE (FLAVIN CONTAINING); IPRONIAZID; PARGYLINE; SEMICARBAZIDE; SODIUM ION; THYROACETIC ACID; THYROID HORMONE; THYRONAMINE; UNCLASSIFIED DRUG; 3-IODOTHYRONAMINE; THYRONINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CATABOLISM; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HEART; HEART MUSCLE CELL; HEART MUSCLE METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE BLOOD LEVEL; HORMONE METABOLISM; KIDNEY PARENCHYMA; LIVER; LUNG PARENCHYMA; MALE; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE; STOMACH; TISSUE DISTRIBUTION; ANIMAL; BLOOD; CELL CULTURE; CHEMISTRY; COMPARATIVE STUDY; HEART MUSCLE; HUMAN; KIDNEY; LUNG; METABOLISM; TANDEM MASS SPECTROMETRY; WISTAR RAT;

ANIMALS; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; KIDNEY; LIVER; LUNG; MALE; MUSCLE, SKELETAL; MYOCARDIUM; MYOCYTES, CARDIAC; RATS; RATS, WISTAR; STOMACH; TANDEM MASS SPECTROMETRY; THYRONINES; TISSUE DISTRIBUTION;

EID: 77957259666     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-0491     Document Type: Article

References (26)

1. Scanlan TS, Suchland KL, Hart ME, Chiellini G, Huang Y, Kruzich PJ, Frascarelli S, Crossley DA, Bunzow JR, Ronca-Testoni S, Lin ET, Hatton D, Zucchi R, Grandy DK 2004 3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone. Nat Med 10:638-642
2. Chiellini G, Frascarelli S, Ghelardoni S, Carnicelli V, Tobias SC, DeBarber A, Brogioni S, Ronca-Testoni S, Cerbai E, Grandy DK, Scanlan TS, Zucchi R 2007 Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function. FASEB J 21:1597-1608
3. Braulke LJ, Klingenspor M, DeBarber A, Tobias SC, Grandy DK, Scanlan TS, Heldmaier G 2008 3-Iodothyronamine: a novel hormone controlling the balance between glucose and lipid utilisation. J Comp Physiol B 178:167-177
4. Zucchi R, Chiellini G, Scanlan TS, Grandy DK 2006 Trace amine-associated receptors and their ligands. Br J Pharmacol 149:967-978
5. Regard JB, Kataoka H, Cano DA, Camerer E, Yin L, Zheng YW, Scanlan TS, Hebrok M, Coughlin SR 2007 Probing cell type-specific functions of Gi in vivo identifies GPCR regulators of insulin secretion. J Clin Invest 117:4034-4043
6. Klieverik LP, Foppen E, Ackermans MT, Serlie MJ, Sauerwein HP, Scanlan TS, Grandy DK, Fliers E, Kalsbeek A 2009 Central effects of thyronamines on glucose metabolism in rats. J Endocrinol 201:377-386
7. Piehl S, Heberer T, Balizs G, Scanlan TS, Smits R, Koksch B, Köhrle J 2008 Thyronamines are isozyme-specific substrates of deiodinases. Endocrinology 149:3037-3045
8. Gereben B, Zavacki AM, Ribich S, Kim BW, Huang SA, Simonides WS, Zeöld A, Bianco AC 2008 Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocr Rev 29:898-938
9. Wood WJ, Geraci T, Nilsen A, DeBarber AE, Scanlan TS 2009 Iodothyronamines are oxidatively deaminated to iodothyroacetic acids in vivo. Chembiochem 10:361-365
10. 1AM) intracellular transport. Endocrinology 150:1991-1999
11. Snead AN, Santos MS, Seal RP, Miyakawa M, Edwards RH, Scanlan TS2007 Thyronamines inhibit plasma membrane and vesicular monoamine transport. ACS Chem Biol 2:390-398
12. Cumero S, Contessi S, Zucchi R, Mavelli I 2010 3-Iodothyronamine favours IF1 release from FOF1 ATP syntase. Biochim Biophys Acta Bioenergetics 1797(Suppl. 1):29 (Abstact)
13. Bunzow JR, Sonders MS, Arttamangkul S, Harrison LM, Zhang G, Quigley DI, Darland T, Suchland KL, Pasumamula S, Kennedy JL, Olson SB, Magenis RE, Amara SG, Grandy DK 2001 Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Mol Pharmacol 60:1181-1188
14. Ghelardoni S, Suffredini S, Frascarelli S, Brogioni S, Chiellini G, Ronca-Testoni S, Grandy DK, Scanlan TS, Cerbai E, Zucchi R 2009 Modulation of cardiac ionic homeostasis by 3-iodothyronamine. J Cell Mol Med 13:3082-3090
15. Hart ME, Suchland KL, Miyakawa M, Bunzow JR, Grandy DK, Scanlan TS 2006 Trace amine-associated receptor agonists: synthesis and evaluation of thyronamines and related analogues. J Med Chem 49:1101-1112
16. Tai SS, Bunk DM, White 5th E, Welch MJ 2004 Development and evaluation of a reference measurement procedure for the determination of total 3,5,3′-triiodothyronine in human serum using isotope-dilution liquid chromatography-tandem mass spectrometry. Anal Chem 76:5092-5096
17. Smith JE, Co C, McIntosh S, Cunningham CC 2008 Chronic binge-like moderate ethanol drinking in rats results in widespread decreases in brain serotonin, dopamine, and norepinephrine turnover rates reversed by ethanol intake. J Neurochem 105:2134-2155
18. van der Putten HH, Joosten BJ, Klaren PH, Everts ME 2002 Uptake of tri-iodothyronine and thyroxine in myoblasts and myotubes of the embryonic heart cell line H9c2. J Endocrinol 175:587-596
19. Verhoeven FA, Van der Putten HH, Hennemann G, Lamers JM, Visser TJ, Everts ME 2002 Uptake of triiodothyronine and triiodothyroacetic acid in neonatal rat cardiomyocytes: effects of metabolites and analogs. J Endocrinol 173:247-255
20. Pedraza PE, Obregon MJ, Escobar-Morreale HF, del Rey FE, de Escobar GM 2006 Mechanism of adaptation to iodine deficiency in rats: thyroid status is tissue specific. Its relevance in man. Endocrinology 147:2098-2108
21. Lyles GA, McAuslane JA, Fitzpatrick CM 1984 Monoanine oxidase activities of dissociated cell fractions from rat ventricular muscle. Biochem Pharmacol 33:2569-2574
22. Pino R, Failli P, Mazzetti L, Buffoni F 1997 Monoamine oxidase and semicarbazide-sensitive amine oxidase activities in isolated cardiomyocytes of spontaneously hypertensive rats. Biochem Mol Med 62:188-196
23. Billett EE 2004 Monoamine oxidase (MAO) in human peripheral tissues. Neurotoxicology 25:139-148
24. Kinemuchi H, Sugimoto H, Obata T, Satoh N, Ueda S 2004 Selective inhibitors of membrane-bound semicarbazide-sensitive amine oxidase (SSAO) activity in mammalian tissues. Neurotoxicology 25:325-335
25. Andrés N, Lizcano JM, Rodríguez MJ, Romera M, Unzeta M, Mahy N 2001 Tissue activity and cellular localization of human semicarbazide-sensitive amine oxidase. J Histochem Cytochem 49:209-217 (Pubitemid 32113383)
26. Wassen FW, Schiel AE, Kuiper GG, Kaptein E, Bakker O, Visser TJ, Simonides WS 2002 Induction of thyroid hormone-degrading deiodinase in cardiac hypertrophy and failure. Endocrinology 143:2812-2825